vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and KFORCE INC (KFRC). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $330.4M, roughly 1.5× KFORCE INC). KFORCE INC runs the higher net margin — 2.4% vs -10.1%, a 12.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 0.1%). KFORCE INC produced more free cash flow last quarter ($-7.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -3.7%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.
CLOV vs KFRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $330.4M |
| Net Profit | $-49.3M | $7.9M |
| Gross Margin | — | 27.3% |
| Operating Margin | -10.1% | 3.6% |
| Net Margin | -10.1% | 2.4% |
| Revenue YoY | 44.7% | 0.1% |
| Net Profit YoY | -123.2% | -2.7% |
| EPS (diluted) | — | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $330.4M | ||
| Q4 25 | $487.7M | $332.0M | ||
| Q3 25 | $496.6M | $332.6M | ||
| Q2 25 | $477.6M | $334.3M | ||
| Q1 25 | $462.3M | $330.0M | ||
| Q4 24 | $337.0M | $343.8M | ||
| Q3 24 | $331.0M | $353.3M | ||
| Q2 24 | $356.3M | $356.3M |
| Q1 26 | — | $7.9M | ||
| Q4 25 | $-49.3M | $5.2M | ||
| Q3 25 | $-24.4M | $11.1M | ||
| Q2 25 | $-10.6M | $10.4M | ||
| Q1 25 | $-1.3M | $8.1M | ||
| Q4 24 | $-22.1M | $11.1M | ||
| Q3 24 | $-9.2M | $14.2M | ||
| Q2 24 | $7.4M | $14.2M |
| Q1 26 | — | 27.3% | ||
| Q4 25 | — | 27.2% | ||
| Q3 25 | — | 27.7% | ||
| Q2 25 | — | 27.1% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | — | 27.0% | ||
| Q3 24 | 24.5% | 27.9% | ||
| Q2 24 | 30.3% | 27.8% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | -10.1% | 2.6% | ||
| Q3 25 | -4.9% | 4.5% | ||
| Q2 25 | -2.2% | 4.5% | ||
| Q1 25 | -0.3% | 3.5% | ||
| Q4 24 | -6.4% | 4.5% | ||
| Q3 24 | -2.7% | 5.3% | ||
| Q2 24 | 2.0% | 5.5% |
| Q1 26 | — | 2.4% | ||
| Q4 25 | -10.1% | 1.6% | ||
| Q3 25 | -4.9% | 3.3% | ||
| Q2 25 | -2.2% | 3.1% | ||
| Q1 25 | -0.3% | 2.5% | ||
| Q4 24 | -6.6% | 3.2% | ||
| Q3 24 | -2.8% | 4.0% | ||
| Q2 24 | 2.1% | 4.0% |
| Q1 26 | — | $0.46 | ||
| Q4 25 | — | $0.29 | ||
| Q3 25 | — | $0.63 | ||
| Q2 25 | — | $0.59 | ||
| Q1 25 | — | $0.45 | ||
| Q4 24 | — | $0.60 | ||
| Q3 24 | — | $0.75 | ||
| Q2 24 | — | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $308.7M | $117.4M |
| Total Assets | $541.0M | $384.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $78.3M | $2.1M | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $444.0K | ||
| Q4 24 | $194.5M | $349.0K | ||
| Q3 24 | $288.0M | $127.0K | ||
| Q2 24 | $254.8M | $110.0K |
| Q1 26 | — | $117.4M | ||
| Q4 25 | $308.7M | $124.6M | ||
| Q3 25 | $340.9M | $132.1M | ||
| Q2 25 | $344.2M | $134.4M | ||
| Q1 25 | $336.1M | $138.0M | ||
| Q4 24 | $341.1M | $154.6M | ||
| Q3 24 | $342.2M | $167.4M | ||
| Q2 24 | $324.9M | $166.6M |
| Q1 26 | — | $384.8M | ||
| Q4 25 | $541.0M | $365.6M | ||
| Q3 25 | $559.7M | $374.2M | ||
| Q2 25 | $575.0M | $373.6M | ||
| Q1 25 | $583.7M | $368.2M | ||
| Q4 24 | $580.7M | $357.8M | ||
| Q3 24 | $653.0M | $369.9M | ||
| Q2 24 | $674.2M | $362.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | — |
| Free Cash FlowOCF − Capex | $-69.0M | $-7.4M |
| FCF MarginFCF / Revenue | -14.1% | -2.2% |
| Capex IntensityCapex / Revenue | 0.4% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | $19.7M | ||
| Q3 25 | $12.1M | $23.3M | ||
| Q2 25 | $5.4M | $18.4M | ||
| Q1 25 | $-16.3M | $249.0K | ||
| Q4 24 | $34.8M | $21.8M | ||
| Q3 24 | $50.0M | $31.0M | ||
| Q2 24 | $44.8M | $20.9M |
| Q1 26 | — | $-7.4M | ||
| Q4 25 | $-69.0M | $16.7M | ||
| Q3 25 | $11.4M | $19.8M | ||
| Q2 25 | $4.8M | $14.2M | ||
| Q1 25 | $-16.5M | $-3.9M | ||
| Q4 24 | $33.3M | $20.9M | ||
| Q3 24 | $49.6M | $27.5M | ||
| Q2 24 | $44.4M | $17.8M |
| Q1 26 | — | -2.2% | ||
| Q4 25 | -14.1% | 5.0% | ||
| Q3 25 | 2.3% | 6.0% | ||
| Q2 25 | 1.0% | 4.3% | ||
| Q1 25 | -3.6% | -1.2% | ||
| Q4 24 | 9.9% | 6.1% | ||
| Q3 24 | 15.0% | 7.8% | ||
| Q2 24 | 12.5% | 5.0% |
| Q1 26 | — | 1.0% | ||
| Q4 25 | 0.4% | 0.9% | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | 0.1% | 1.2% | ||
| Q1 25 | 0.0% | 1.3% | ||
| Q4 24 | 0.5% | 0.3% | ||
| Q3 24 | 0.1% | 1.0% | ||
| Q2 24 | 0.1% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.82× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 1.97× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | 6.04× | 1.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
